Related Experiment Videos
Long-term rectal administration of high-dose sustained-release morphine tablets
Declan Walsh1, Pamela S Tropiano
1The Harry R. Horvitz Center for Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland, OH 44195, USA. walsht@ccf.org
Summary
Rectal administration of sustained-release morphine tablets offers excellent pain relief for cancer patients. This alternative route provides effective analgesia, though it is not FDA-approved for this method.
Area of Science:
- Oncology
- Pharmacology
- Pain Management
Background:
- Sustained-release morphine tablets are approved for oral use in the USA.
- Effective pain management is crucial for patients with advanced cancer.
Observation:
- Two proprietary sustained-release morphine formulations were administered rectally.
- Excellent analgesia was observed following rectal administration.
Findings:
- Rectal administration of oral sustained-release morphine tablets provides effective pain relief.
- This route bypasses oral limitations, offering an alternative for pain management.
Implications:
- Rectal morphine may be a viable option for managing cancer pain, especially when oral administration is challenging.
- Further research into the efficacy and safety of this off-label use is warranted.